You have 9 free searches left this month | for more free features.

ER OROS Paliperidone

Showing 1 - 25 of 1,514

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Schizophrenia Trial in Worldwide (Paliperidone ER)

Completed
  • Schizophrenia
  • Paliperidone ER
  • Antwerpen, Belgium
  • +235 more
Mar 23, 2021

Eating Rate Trial in Wageningen (ultra-processed slow eating rate diet, Ultra-processed fast eating rate diet)

Recruiting
  • Eating Rate
  • ultra-processed slow eating rate diet
  • Ultra-processed fast eating rate diet
  • Wageningen, Gelderland, Netherlands
    Wageningen University
Nov 3, 2023

Prurigo Nodularis Trial in Worldwide (Nalbuphine ER Tablets, Matching Placebo Tablets)

Active, not recruiting
  • Prurigo Nodularis
  • Nalbuphine ER Tablets
  • Matching Placebo Tablets
  • Phoenix, Arizona
  • +69 more
Jan 31, 2023

Chronic Pain, Musculoskeletal Pain, Fibromyalgia Trial in Palo Alto (Empowered Relief for Youth)

Recruiting
  • Chronic Pain
  • +5 more
  • Empowered Relief for Youth
  • Palo Alto, California
    Stanford University
Aug 9, 2023

Esophageal Cancer Trial in Guangzhou (Submucosal Saline Injection, Blue laser Imaging and Magnifying Endoscopy)

Recruiting
  • Esophageal Cancer
  • Submucosal Saline Injection
  • Blue laser Imaging and Magnifying Endoscopy
  • Guangzhou, Guangdong, China
    Cancer center, Sun Yat-sen University
Aug 28, 2023

Schizophrenia Trial in United States (ASP4345, , risperidone)

Completed
  • Schizophrenia
  • Cerritos, California
  • +26 more
Apr 14, 2022

Assessed by 18F-FES PET/CT in MBC With ER-positive Primary Tumor

Recruiting
  • Breast Cancer
    • Shanghai, Shanghai, China
      Biyun Wang, MD
    Apr 5, 2023

    OCD Trial in Braga (ICBT)

    Recruiting
    • Obsessive-Compulsive Disorder
    • ICBT
    • Braga, Gualtar, Portugal
      Life and Health Sciences Research Institute, School of Medicine,
    Jun 6, 2023

    Breast Cancer Trial in Shijiazhuang (Dalpiciclib, Aromatase inhibitor, Docetaxel injection)

    Recruiting
    • Breast Cancer
    • Shijiazhuang, Hebei, China
      The Fourth Hospital of Hebei Medical University
    Oct 25, 2023

    Breast Cancer Female, Lobular Breast Carcinoma, PET/MRI Trial (drug, procedure, genetic)

    Not yet recruiting
    • Breast Cancer Female
    • +4 more
    • (no location specified)
    Aug 8, 2023

    Schizophrenia Trial in Goyang-si, Seoul (paliperidone)

    Completed
    • Schizophrenia
    • Goyang-si, Korea, Republic of
    • +1 more
    Apr 7, 2019

    Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Stage I Trial in Shanghai (FWD1802, palbocilib)

    Recruiting
    • Metastatic Breast Cancer
    • +3 more
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Sep 26, 2023

    Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

    Recruiting
    • Hormone Receptor Positive HER-2 Negative Breast Cancer
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Jun 12, 2023

    Breast Cancer Trial in Beijing (18F-FES PET/CT scan)

    Recruiting
    • Breast Cancer
    • 18F-FES PET/CT scan
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Nov 4, 2022

    Nalbuphine, Idiopathic Pulmonary Fibrosis, Cough Trial in United Kingdom (Nalbuphine ER, Placebo oral tablet)

    Completed
    • Nalbuphine
    • +2 more
    • Nalbuphine ER
    • Placebo oral tablet
    • Antrim, Northern Ireland, United Kingdom
    • +14 more
    Oct 3, 2022

    Metastatic Breast Cancer Trial in Springfield, Rochester, Lebanon (17B-estradiol, Letrozole, Anastrozole)

    Active, not recruiting
    • Metastatic Breast Cancer
    • Springfield, Massachusetts
    • +2 more
    Nov 1, 2022

    Pain, Chronic Trial (Empowered Relief)

    Not yet recruiting
    • Pain, Chronic
    • Empowered Relief
    • (no location specified)
    Jun 27, 2023

    Estrogen Receptor Positive Breast Cancer Trial in Edmonton (Estradiol)

    Active, not recruiting
    • Estrogen Receptor Positive Breast Cancer
    • Edmonton, Alberta, Canada
      Cross Cancer Institute
    Feb 1, 2023

    Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

    Recruiting
    • Advanced Triple-Negative Breast Carcinoma
    • +4 more
    • Biopsy
    • +4 more
    • Birmingham, Alabama
    • +9 more
    Aug 31, 2022

    Epidemic Disease, Infections Trial in Hillerød (virtual Hospital at Home (vHaH))

    Recruiting
    • Epidemic Disease
    • Infections
    • virtual Hospital at Home (vHaH)
    • Hillerød, Denmark
      Department of Pulmonary and Infectious Diseases, Nordsjællands H
    Jun 16, 2023

    Emotion Regulation Trial in Oxford (Laboratory tasks in middle childhood/pre-adolescence)

    Not yet recruiting
    • Emotion Regulation
    • Laboratory tasks in middle childhood/pre-adolescence
    • Oxford, Ohio
      Miami University Department of Psychology
    Jun 10, 2022

    ER+ HER2- Advanced Breast Cancer Trial in Chuo-ku, Kashiwa, Koto-ku (AZD9833)

    Active, not recruiting
    • ER+ HER2- Advanced Breast Cancer
    • Chuo-ku, Japan
    • +2 more
    Jan 24, 2023

    Advanced Cancer Trial in Taichung, Tainan (CVM-1118 Extended-Release (ER) Capsules (200 mg/capsule))

    Completed
    • Advanced Cancer
    • CVM-1118 Extended-Release (ER) Capsules (200 mg/capsule)
    • Taichung, Taiwan
    • +1 more
    Nov 25, 2022

    ER+, HER2- Advanced Breast Cancer, Metastatic Breast Cancer Trial in Luoyang, Shanghai (TFX06 tablet)

    Recruiting
    • ER+, HER2- Advanced Breast Cancer
    • Metastatic Breast Cancer
    • TFX06 tablet
    • Luoyang, Henan, China
    • +1 more
    Jun 25, 2023